Much-debated Alzheimer’s drug gets FDA nod

Much-debated Alzheimer’s drug gets FDA nod

Washington, June 7

The Food and Drug Administration (FDA) on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. — AP

Mali junta leader sworn in as Prez after 2nd coup

Bamako: Mali’s coup leader Col Assimi Goita was sworn in Monday as president of a transitional government, solidifying his grip on power in the West African nation after carrying out his second coup d’etat in nine months. The inauguration ceremony came as Mali faces international isolation. — AP


Please enter your comment!
Please enter your name here